Eliminate HIV

Ending the HIV epidemic as a public health threat is now a real possibility.

Globally, an estimated 36.7 million people were living with HIV, with 46 percent on life-saving antiretroviral treatment, according to the World Health Organization.

In Australia, more than 26,400 people were living with HIV in 2016 and according to annual HIV surveillance data more than 10 percent were unaware of their HIV-positive status.

The goals of our Eliminate HIV program include:

To facilitate reductions in new HIV infections in Australia and internationally through an improved understanding of the major drivers of transmission.
To work towards HIV elimination by addressing key barriers to the implementation of evidence-based HIV prevention programs, and expanding access to HIV diagnosis and treatment.
Use basic, discovery and translational research to develop, trial and implement new strategies and tools that assist in the prevention, diagnosis and treatment of HIV.

Contact Details

Chad Hughes

Deputy Program Director, Disease Elimination

Telephone

+61392822214

Email

chad.hughes@burnet.edu.au

Projects

A novel biomarker for gut leakage as a diagnostic tool for HIV disease progression
Investigating a novel plasma biomarker's potential for identifying gut leakage.
Accelerating ART initiation among Infants (AAMI Study)
This project will trial the POC VISITECT® CD4 test and POC LYNX HIV p24 early infant diagnostic test.
Access to affordable and accurate HIV-1 VL testing
Laboratory evaluation of a novel filter paper-based method of plasma separation for viral load testing.
Access to CD4 (VISITECT® CD4) testing among HIV-infected women in Kenya
An accessible CD4 (VISITECT® CD4) test for HIV-infected pregnant and postpartum women in Kenya.
ACCESS: STI and BBV surveillance system
ACCESS is a surveillance system that collates important information on a range of STIs and BBVs.
Antibody mAbs to destroy infection: engineering the next generation treatments
Applying discoveries from our cancer mAb program to neutralize and destroy pathogens.
Broadly neutralising anti-HIV antibodies and Fc Receptor function
Defining the properties of anti-HIV antibodies for vaccine development and protection of pregnant women.
co-EC Study: Eliminating hepatitis C/HIV coinfection
Eliminating hepatitis C transmission by enhancing care and treatment among HIV co-infected individuals.
Community-Based Rapid HIV Testing Services
Evaluating a multi-site rapid HIV testing trial in South Australia and rural site in Bendigo, Victoria.
DARE C: ATAHC II Substudy
DARE-C aims to evaluate therapy duration using triple therapy (PEG-IFN/RBV/TPV).
Decision science using Optima
Research and applications across disease areas to improve allocative efficiency.
Developing new HIV disease progression tests
This project will develop prognostic tools to identify HIV+ persons at risk of rapid disease progression.
Development of a novel prophylactic vaccine candidate for HIV-1
A prophylactic vaccine represents the best strategy for blocking HIV-1 transmission.
Harm reduction among People who Inject Drugs in Myanmar
Aims to prevent the transmission of HIV among young people, students, migrant and transport workers.
HIV Prevention Cohort
Online cohort study of gay men in Victoria monitoring community-level change.
HIV testing among young men who have sex with men in Myanmar
Examining factors associated with HIV testing uptake among young men who have sex with men in Myanmar.
Plasma separator device for HIV viral load testing
Aimed at improving access to HIV viral load assays in resource-limited settings.
Predicting quality and potency of monoclonal and natural antibodies
Rapid, simple and scalable assays for predicting antibody potency.
PrEPX: Rapid scale-up of HIV pre-exposure prophylaxis (PrEP)
Burnet is playing a crucial role in monitoring the outcomes of the PrEPX trial in Victoria.
PRONTO! Rapid HIV point-of-care testing in Victoria
The first rapid HIV test service in Victoria targeting gay men and men who have sex with men.
Sexual Health And Risk Prevention (SHARP) Study
Assessing responses to HIV prevention measures among Australian MSM.
TAIPAN: HIV cascade surveillance
Internationally novel project to create a linked surveillance system to monitor the HIV cascade for gay men
The Victorian Primary Care Network for Sentinel Surveillance on BBVs and STIs
The surveillance involves collection and linking of testing, demographic, and risk behaviour information.
Transmitted and acquired drug resistant HIV strains in Victoria, Australia
Documenting mutations associated with drug resistance acquired by patients diagnosed with HIV.
VISITECT® CD4 point-of-care test
An affordable HIV point-of-care test developed by Burnet but licensed to Omega Diagnostics.

Latest News

26 January, 2019

Australia Day Honours for Burnet staff and associates

Congratulations to Professor Margaret Hellard, Professor Sharon Lewin, and former board member Mr Ross Cooke.
21 January, 2019

Burnet at Midsumma

Burnet researchers were kept busy fielding questions from the curious public and interested supporters at Sunday’s 2019 Midsumma Carnival.

Upcoming Events

21 July, 2019

IAS 2019

Burnet Institute’s Dr Sherrie Kelly will be a Plenary Session speaker at the 10th IAS Conference on HIV Science (IAS 2019) in Mexico.
04 September, 2019

Contemporary Drug Problems Conference

Professor Mark Stoové is a member of the organising committee for the 2019 Contemporary Drug Problems Conference in Prato, Italy.

Our mission:

To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.

Contact Us

85 Commercial Road, Melbourne
VIC, 3004, Australia

E: reception@burnet.edu.au
T: +61 3 9282 2111

Intranet Site Map Careers

Disclaimer Privacy Policy Complaints Policy

This website was developed with the generous support of a donor.

Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung and Wurundjeri people and we offer our respects to the elders past and present.
We recognise and respect the cultural heritage of this land.

Reduce HIV transmissions in Australia Appeal

Support Our Work

Burnet Institute: Medical Research. Practical Action.

Equity through better health

Eliminate HIV